RK

Rajiv Krishna

Active Director Director DIN 11138537
DIN 11138537 First appointment Aug 2025 Primary industry Healthcare
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Aug 2025
Shareholding value β€’β€’β€’β€’ Premium profile

About Rajiv Krishna

Data last updated:

Rajiv Krishna is a Director at Amartya Medicare Private Limited (since 2025). The company operates in Healthcare.

DIN 11138537
Primary Designation Director
Industry Healthcare
First Appointment 02 Aug 2025
Oldest Company Age 1 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Amartya Medicare Private Limited U86100BR2025PTC077839
Director02 Aug 20252025Active

Directorship timeline

Open interactive timeline →
Amartya Medicare Private Limited
Premium access

Shareholding and investment profile for Rajiv Krishna

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Rajiv Krishna

Rajiv Krishna currently holds 1 directorship: Amartya Medicare Private Limited (Director, since 02 Aug 2025).

Rajiv Krishna was first appointed on 02 Aug 2025 as Director at Amartya Medicare Private Limited.

The current boards of Rajiv Krishna's companies include Abhinav Bhagat (Amartya Medicare Private Limited), Anwar Alam (Amartya Medicare Private Limited), Dhananjay Kumar Suman (Amartya Medicare Private Limited), Kawaljit Singh Gandhi (Amartya Medicare Private Limited), Nitish Kumar (Amartya Medicare Private Limited), Sanjeev Kumar (Amartya Medicare Private Limited), among others.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available